Percutaneous coronary intervention in a patient with von Willebrand's disease presenting with an acute coronary syndrome

Journal of Invasive Cardiology

Volumn 18, Issue 4, 2006, Pages 174-177

  Macdonald, John ^a   Srinivasan, Manivannan ^a   More, Ranjit ^a  

^a BLACKPOOL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIANGINA PECTORIS AGENT; C REACTIVE PROTEIN; CHOLESTEROL; CLOPIDOGREL; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; PACLITAXEL; VON WILLEBRAND FACTOR; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ADULT; ANTICOAGULATION; ARTICLE; CASE REPORT; HEART PROTECTION; HEMOSTASIS; HUMAN; MALE; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN DETERMINATION; SYNDROME DELINEATION; THROMBOCYTE AGGREGATION INHIBITION; VON WILLEBRAND DISEASE; ACUTE DISEASE; ANGIOCARDIOGRAPHY; CHEMICALLY INDUCED DISORDER; CORONARY ARTERY DISEASE; EPISTAXIS; MIDDLE AGED; RADIOGRAPHY; REVIEW; STENT; SYNDROME; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE DISEASE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; EPISTAXIS; HEPARIN; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; STENTS; SYNDROME; TICLOPIDINE; VON WILLEBRAND DISEASE;

EID: 33745105384     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Sadler JE. von Willebrand Factor. J Biol Chem 1991;266:22777-22780.
2. Griggs TR, Reddick RL, Sultzer D, et al. Susceptibility to atherosclerosis in aortas and coronary arteries of swine with von Willebrand's disease. Am J Pathol 1981;102:137-145.
3. Griggs TR, Bauman RW, Reddick RL, et al. Development of coronary atherosclerosis in swine with severe hypercholesterolemia. Lack of influence of von Willebrand factor or acute intimal injury. Arteriosclerosis 1986;6:155-165.
4. Nichols TC, Bellinger DA, Johnson TA, et al. von Willebrand's disease prevents occlusive thrombosis in stenosed and injured porcine coronary arteries. Circ Res 1986;59:15-26.
5. Nichols TC, Bellinger DA, Tate DA, et al. von Willebrand factor and occlusive arterial thrombosis. A study in normal and von Willebrand's disease pigs with diet-induced hypercholesterolemia and atherosclerosis. Arteriosclerosis 1990;10:449-461.
6. Kernoff LM, Rose AG, Hughes J, et al. Autopsy findings in an elderly man suffering from severe von Willebrand's Disease. Thromb Haemost 1981;46:714-746.
7. Dulhoste MN, Bonnet J, Vergnes C, et al. von Willebrand's disease and coronary atherosclerosis. Apropos of 3 cases. Arch Mal Coeur Vaiss 1989;82:1875-1888.
8. Bilora F, Dei Rossi C, Girolami B, et al. Do Hemophilia A and von Willebrand disease protect against carotid atherosclerosis? A comparative study between coagulopathics and normal subjects by means of carotid echo-Color Doppler scan. Clin Appl Thromb Hemost 1999;5:232-235.
9. Bilora F, Boccioletti V, Zanon E, et al. Hemophilia A, von Willebrand disease and atherosclerosis of abdominal aorta and leg arteries: Factor VIII and von Willebrand factor defects appear to protect abdominal aorta and leg arteries from atherosclerosis. Clin Appl Thromb Hemost 2001;7:311-313.
10. Whincup PH, Danesh J, Walker M, et al. von Willebrand factor and coronary heart disease: Prospective study and meta-analysis. Eur Heart J 2002;23:1764-1770.
11. Morange PE, Simon C, Alessi MC, et al. Endothelial cell markers and the risk of coronary heart disease: The prospective epidemiological study of myocardial infarction (PRIME) study. Circulation 2004;109:1343-1348.
12. Mannucci PM. von Willebrand factor: A marker of endothelial damage? Arterioscler Thromb Vasc Biol 1998;18:1359-1362.
13. Pottinger BE, Read RC, Paleolog EM, et al. von Willebrand factor is an acute phase reactant in man. Thromb Res 1989;53:387-394.
14. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-1397.
15. Yarnell JW, Sweetnam PM, Rumley A, et al. Lifestyle and hemostatic risk factors for ischemic heart disease: The Caerphilly study. Arterioscler Thromb Vasc Biol 2000;20:271-279.
16. Barbui T, Rodeghiero F, Dini E. The aspirin tolerance test in von Willebrand's disease. Thromb Haemost 1977;38:510-513.
17. Pernerstorfer T, Eichler HG, Stohlawetz P, et al. Effects of heparin and aspirin on circulating P-selectin, E-selectin and von Willebrand factor levels in healthy men. Atherosclerosis 2001;155:389-393.
18. Bussey H, Francis JL. Heparin overview and issues. Pharmacotherapy 2004;24(Pt 2):103S-107S.
19. Fragasso G, Camba L, Pizzetti G, et al. Successful thrombolysis for acute myocardial infarction in Type I von Willebrand's disease (VWD). Am J Hematol 1998;57:180.
20. Wong CB, Schreiber TL. Acute myocardial infarction in a patient with von Willebrand disease. Cathet Cardiovasc Diagn 1996;38:287-278.
21. Sakai H, Goto S, Kim JY, et al. Plasma concentration of von Willebrand factor in acute myocardial infarction. Thromb Haemost 2000;84:204-209.
22. Rickles FR, Hoyer LW, Rick ME, et al. The effects of epinephrine infusion in patients with von Willebrand's disease. J Clin Invest 1976;57:1618-1625.
23. James PR, de Belder AJ, Kenny MW. Successful percutaneous transluminal coronary angioplasty for acute myocardial infarction in von Willebrand's disease. Haemophilia 2002;8:826-827.
24. Al Suwaidi J, Holmes DR Jr, Salam AM, et al. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: Meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty. Am.Heart J 2004;147:815-822.
25. Kong DF, Califf RM, Miller DP, et al. Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease. Circulation 1998;98:2829-2835.
26. Jeremias A, Sylvia B, Bridges J, et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 2004;109:1930-1932.
27. Kerner A, Gruberg L, Kapeliovich M, et al. Late stent thrombosis after implantation of a sirolimus-eluting stent. Catheter Cardiovasc Interv 2003;60:505-508.
28. Levine GN, Kern MJ, Berger PB, et al. American Heart Association Diagnostic and Interventional Catheterization Committee and Council on Clinical Cardiology. Management of patients undergoing percutaneous coronary revascularization. Ann Intern Med 2003;139:123-136.
29. Agostoni P, Biondi-Zoccai GG, de Benedictis ML, et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures: Systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol 2004;44:349-356.